Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INAB

IN8BIO, INC.

CIK 0001740279 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.28
↑ 0.07 (5.79%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$12.27M
P/E Ratio
-0.66
EPS
-4.44
Dividend Yield
Not covered
52W Position
22%
Beta
1.59

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.67
P/S
Not covered
EV/Revenue
Not covered
ROE
-101.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$0.88$2.73

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$19.44M
Total Assets
$32.28M
Free Cash Flow
–

Recent news